April 2018 BSG guide for sonographers and primary care. Please note this is a draft document for consultation. Click HERE to access the document.
XXXI course on Musculoskeletal Pathology is being held on 16-20 April 2018, Istituto Ortopedico Rizzoli, Bologna, Italy. For further information please CLICK HERE.
BSG guide for sonographers and primary care. Please note this is a draft document for consultation. Click here to read the document.
The BSG programme is now available to view. Further updates may be made. Please click HERE for the BSG 2 day programme, 27.02.18 & Wednesday, 28.02.18. The National Sarcoma Forum is being held on the afternoon of Tuesday, 27.02.18. Please click HERE for the NSF programme, 27.02.18. We hope to see you in February for […]
We’re delighted to announce that registration for the first joint British Sarcoma & Irish Sarcoma Group conference is now open! You can register your place by clicking HERE The conference takes place across two days – Tuesday 27th & Wednesday 28th February 2018. There are a number of different ticket options available and all rates […]
Thank you to everyone who has submitted an abstract for 2018 conference. We’ve received a record number of papers and all notifications have been sent for successful oral and poster presentations. Any queries, please contact: email@example.com
Following on from the publication of exciting data from a phase 2 trial last year, NICE has now approved use of olaratumab in combination with doxorubicin for advanced soft tissue sarcoma (STS) in the first-line setting. Doxorubicin has been the backbone of first line chemotherapy for STS for over 30 years and the early data […]
Consider signing up for Soft-Tissue-Sarcoma-a-Clinical-Update-2017 on the 26th September, hosted by the Royal Marsden Hospital.
Prof. Ian Judson has led authorship of the UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST) which have just been published, joining the guidelines for soft tissue, and bone sarcoma published last year. These should provide a valuable resource for sarcoma services nationally to ensure consistent and evidence-based practice.